Clinical Trial Update: Anti-PD-1 in Combination With Chemotherapy as First-Line Treatment to Lung Cancer [Phase 2]

View source ↗

Summary

Phase 2 results for tislelizumab in combination with chemotherapy as first-line treatment for locally advanced or metastatic non-small cell lung cancer have com…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Tislelizumab (tislelizumab)

Snippet

Sponsor: BeiGene | Conditions: Locally Advanced Lung Cancer; Metastatic Lung Cancer | Phase 2 | Status: COMPLETED